Dr Cho Rong Hong
Research Fellow
Dr
Cho Rong
Hong
Dr Cho Rong Hong
https://unidirectory.auckland.ac.nz/profile/c-hong
Research Fellow
The University of Auckland: Auckland Cancer Society Research Centre
Selected publications and creative works (Research Outputs)
As of 29 October 2020 there will be no automatic updating of 'selected publications and creative works' from Research Outputs. Please continue to keep your
Research Outputs profile up to date.
- Hong, C. R., Wilson, W. R., & Hicks, K. O. (2019). An Intratumor Pharmacokinetic/Pharmacodynamic Model for the Hypoxia-Activated Prodrug Evofosfamide (TH-302): Monotherapy Activity is Not Dependent on a Bystander Effect. Neoplasia (New York, N.Y.), 21 (2), 159-171. 10.1016/j.neo.2018.11.009
Other University of Auckland co-authors: Kevin Hicks - Mao, X., McManaway, S., Jaiswal, J. K., Hong, C. R., Wilson, W. R., & Hicks, K. O. (2019). Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000. Cancer biology & therapy, 20 (9), 1258-1269. 10.1080/15384047.2019.1617570
Other University of Auckland co-authors: Jagdish Jaiswal, Kevin Hicks - Hong, C. R., Dickson, B. D., Jaiswal, J. K., Pruijn, F. B., Hunter, F. W., Hay, M. P., ... Wilson, W. R. (2018). Cellular pharmacology of evofosfamide (TH-302): A critical re-evaluation of its bystander effects. Biochemical Pharmacology, 156, 265-280. 10.1016/j.bcp.2018.08.027
Other University of Auckland co-authors: Benjamin Dickson, Michael Hay, Jagdish Jaiswal, Frederik Pruijn, Francis Hunter, Kevin Hicks - Jamieson, S. M., Tsai, P., Kondratyev, M. K., Budhani, P., Liu, A., Senzer, N. N., ... Kee, D. (2018). Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma. JCI insight, 3 (16).10.1172/jci.insight.122204
Other University of Auckland co-authors: Francis Hunter, Stephen Jamieson, Peter Tsai, Avik Shome, Way Wong, Nicholas Knowlton, Tet Woo Lee, Kevin Hicks, Stefan Bohlander, Purvi Kakadiya, Cristin Print, Courtney Lynch, Nooriyan Poonawala-Lohani - Hong, C. R. (2018). Investigation of bystander effects of hypoxia-activated prodrugs using three dimensional cell cultures The University of Auckland. ResearchSpace@Auckland.
- Hong, C. R., Bogle, G., Wang, J., Patel, K., Pruijn, F. B., Wilson, W. R., & Hicks, K. O. (2018). Bystander Effects of Hypoxia-Activated Prodrugs: Agent-Based Modeling Using Three Dimensional Cell Cultures. Frontiers in pharmacology, 910.3389/fphar.2018.01013
Other University of Auckland co-authors: Kevin Hicks, Gib Bogle, Frederik Pruijn - Bonnet, M., Hong, C. R., Wong, W. W., Liew, L. P., Shome, A., Wang, J., ... Anderson, R. F. (2018). Next-generation hypoxic cell radiosensitizers: Nitroimidazole alkylsulfonamides. Journal of Medicinal Chemistry, 61 (3), 1241-1254. 10.1021/acs.jmedchem.7b01678
Other University of Auckland co-authors: Michael Hay, Lydia Liew, Way Wong, Bob Anderson, Stephen Jamieson, Kevin Hicks, Frederik Pruijn, Yongchuan Gu, Avik Shome - Hunter, F., Shome, A., Wong, W. W., Budhani, P., Senzer, N., Chiorean, E. G., ... Kakadiya, P. (2017). Efficacy and sensitivity determinants of evofosfamide in head and neck squamous cell carcinoma. Paper presented at The New Zealand Society for Oncology 2017 Conference, Auckland, New Zealand. 14 October - 15 October 2017.
Other University of Auckland co-authors: Francis Hunter, Avik Shome, Way Wong, Nooriyan Poonawala-Lohani, Purvi Kakadiya, Courtney Lynch, Tet Woo Lee, Kevin Hicks, Stefan Bohlander, Cristin Print, Stephen Jamieson
Contact details
Primary office location
M&HS BUILDING 504 - Bldg 504
Level 0, Room 005
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand